● Recruiting

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Condition: Advanced Solid Tumors · Genital Neoplasm, Female · Urogenital Neoplasms · Sponsor: Marengo Therapeutics, Inc.

PhasePhase 1/Phase 2

Planned participants365

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This is an open label, multicenter, phase 1/2 study to assess the safety/tolerability and preliminary clinical activity of STAR0602 as a single agent administered intravenously in participants with advanced solid tumors that are antigen-rich.

This description comes directly from the study's public registry record.

Talk to the study team

Ke Liu, MD, PhD · +1 (617) 917-4980 · kliu@marengotx.com

Always discuss trial participation with your own doctor first.

Locations (32)

Loma Linda University Cancer Center	Loma Linda, California, United States	Recruiting
UC Davis Comprehensive Cancer Center	Sacramento, California, United States	Recruiting
Sarah Cannon Research Institute at HealthONE	Denver, Colorado, United States	Recruiting
AdventHealth Celebration	Celebration, Florida, United States	Recruiting
University of Miami Sylvester Comprehensive Cancer Center	Miami, Florida, United States	Recruiting
The University of Kansas Cancer Center	Kansas City, Kansas, United States	Recruiting
National Institutes of Health	Bethesda, Maryland, United States	Recruiting
Massachusetts General Hospital Cancer Center	Boston, Massachusetts, United States	Recruiting
Dana-Farber Cancer Institute	Boston, Massachusetts, United States	Recruiting
Karmanos Cancer Institute	Detroit, Michigan, United States	Recruiting
Memorial Sloan-Kettering Cancer Center	New York, New York, United States	Recruiting
The Ohio State University Comprehensive Cancer Center	Columbus, Ohio, United States	Recruiting

+ 20 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05592626